王婵娟,朱 熹.EMT介导膀胱癌耐药的机制及相关分子[J].肿瘤学杂志,2018,24(8):813-817.
EMT介导膀胱癌耐药的机制及相关分子
Mechanisms and Related Molecules of EMT-induced Chemoresistancein Bladder Cancer
投稿时间:2017-06-06  
DOI:10.11735/j.issn.1671-170X.2018.08.B012
中文关键词:  膀胱肿瘤  上皮-间充质转化  化疗耐药  信号分子
英文关键词:urinary bladder neoplasms  epithelial-mesenchymal transition  chemoresistance  signaling molecules
基金项目:国家自然科学基金资助项目(61401290);北京市医院管理局青年人才培养“青苗”计划(QML20160104)
作者单位
王婵娟 北京大学第三医院 
朱 熹 首都医科大学附属北京友谊医院 
摘要点击次数: 1688
全文下载次数: 406
中文摘要:
      摘 要:化疗是治疗膀胱癌的重要手段,但是随着化疗的进行,肿瘤细胞往往对单药或多药化疗产生耐药,严重影响患者的预后。近年来研究表明,膀胱癌耐药性的产生受肿瘤微环境中多种信号分子的调节,上皮-间充质转化 (epithelial-mesenchymal transition,EMT)在其中发挥着关键性作用,多种分子通过不同的信号通路参与到EMT介导的膀胱癌耐药机制中。全文就EMT相关耐药机制进行探讨,旨在为EMT介导的耐药膀胱癌患者寻找新的治疗策略。
英文摘要:
      Abstract:Chemotherapy plays an important role in the treatment of bladder cancer. However,the use of chemotherapeuticsmore than often leads to development of resistance in cancer cells to single- or multi-drug therapy,which seriously affects the prognosis of patients.Recent studies show that chemoresistance is regulated by varioustypes of signaling molecules in the tumor microenvironment,and that epithelial-mesenchymal transition(EMT) plays a crucial part in this process. Different types of molecules can participate in EMT-induced chemoresistance via different signaling pathways. In this review,the mechanisms of EMT-relatedchemoresistancewere identified in attempt to formulate new therapeutic strategies for bladder cancer patients who have developed chemoresistance.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器